EC Number   |
Title |
Organism |
|---|
   3.4.21.B60 | A common TMPRSS2 variant has a protective effect against severe COVID-19 |
Homo sapiens |
| 3.4.21.B60 | ACE2 and TMPRSS2 immunolocalization and oral manifestations of COVID-19 |
Homo sapiens |
| 3.4.21.B60 | Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells |
Mesocricetus auratus |
| 3.4.21.B60 | Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells |
Capra hircus |
| 3.4.21.B60 | Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells |
Homo sapiens |
| 3.4.21.B60 | Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells |
Felis catus |
| 3.4.21.B60 | Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies |
Homo sapiens |
| 3.4.21.B60 | Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 |
Homo sapiens |
| 3.4.21.B60 | Estradiol reduces ACE2 and TMPRSS2 mRNA levels in A549 human lung epithelial cells |
Homo sapiens |
| 3.4.21.B60 | In silico analysis and synthesis of nafamostat derivatives and evaluation of their anti-SARS-CoV-2 activity |
Homo sapiens |
